VANOMED
ActiveFrom the official registers: KBO 35 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
VANOMED has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €646,016 and a net result of €134,402. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 55% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Mandate history
- Board
- end not dated
| Name | Functions and periods |
|---|---|
| VANOUTRYVE JOHAN |
|
| Vanoutryve |
|
How the board is organised
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Natuurlijke personen of rechtspersonen, één of meer bestuurders”
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, algemene vergadering”
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- One provision in the deed
Articles of association, deed of 06-11-2023 (in Dutch)
Owners and capital
Capital and shareholders
- 06-11-2023 Converted to unavailable equity
Shares according to the articles of association
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Aandelen op naam, bestuursorgaan”
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Helft overdrager,helft kopers naar evenredigheid, werkelijke waarde dag overdracht zonder patiëntenbestand”
- Share issue ruleHow and by whom new shares can be issued.
- “Inbreng in geld met nieuwe aandelen, ten minste vijftien dagen vanaf openstelling”
Other provisionsRules from the articles on subjects other than the board, the shares, the purpose and the meetings.
Articles of association, deed of 06-11-2023 (in Dutch)